Header Logo

Connection

Weiyi Peng to Glutaminase

Back to Details
This is a "connection" page, showing publications Weiyi Peng has written about Glutaminase.
Weiyi Peng
Connection Strength
0.176
Glutaminase
  1. The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies. Mol Cancer Ther. 2021 Mar; 20(3):500-511.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.